Form 4: Outset Medical SVP Operations and R&D, Marc Nash, Sells Shares to Cover Tax Obligations

Marc Nash, SVP Operations and R&D at Outset Medical, sold 4,204 shares of common stock to cover tax withholding obligations related to vesting RSUs.

Summary

• On February 18, 2025, Marc Nash, SVP Operations and R&D at Outset Medical, Inc., sold 4,204 shares of common stock.
• The sale was executed at a price of $0.9 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of 11,581 shares of common stock underlying RSUs.
• Following the transaction, Nash directly owns 200,764 shares of Outset Medical, Inc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell to cover taxes) and does not contain any information that would significantly impact investor sentiment positively or negatively.

Management Comments

• This sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.

Industry Context

Executive stock sales to cover tax obligations upon vesting of restricted stock units (RSUs) are a common practice in publicly traded companies.

Comparison to Industry Standards

• Executive compensation packages often include RSUs, which vest over time and are subject to income tax.
• To cover these taxes, executives frequently use 'sell to cover' transactions, where a portion of the newly vested shares are sold automatically.
• This practice is widespread among companies of all sizes and is not unique to Outset Medical.

Key Dates

Keywords

Outset Medical, Marc Nash, Stock Sale, Form 4, RSUs, Tax Withholding, Beneficial Ownership, SVP Operations, R&D